Case-control study of evening melatonin concentration in primary insomnia.

Case-control study of evening melatonin concentration in primary insomnia.

Bibliographic Details
Main Authors:	Attenburrow, M, Dowling, B, Sharpley, A, Cowen, P
Format:	Journal article
Language:	English
Published:	1996

Similar Items

Assessment and treatment of insomnia (including a case control study of patients with Primary Insomnia).
by: Sharpley, A, et al.
Published: (1997)

Melatonin phase advances circadian rhythm.
by: Attenburrow, M, et al.
Published: (1995)

Low dose melatonin improves sleep in healthy middle-aged subjects.
by: Attenburrow, M, et al.
Published: (1996)

Effect of idazoxan on evening melatonin plasma concentrations in healthy volunteers.
by: Grasby, P, et al.
Published: (1989)

Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients.
by: Sharpley, A, et al.
Published: (2005)

Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
by: Sharpley, A, et al.
Published: (1994)

The effects of paroxetine and nefazodone on sleep: a placebo controlled trial.
by: Sharpley, A, et al.
Published: (1996)

Melatonin, insomnia and the use of melatonergic drugs
by: Srinivasan, Venkatramanujam, et al.
Published: (2012)

Atenolol reduces plasma melatonin concentration in man.
by: Cowen, P, et al.
Published: (1983)

INSOMNIA AND CIRCADIAN RHYTHMS OF MELATONIN IN MENOPAUSAL WOMEN
by: N. V. Semenova, et al.
Published: (2018-09-01)

MELATONIN DAN MELATONIN RECEPTOR AGONIST SEBAGAI PENANGANAN INSOMNIA PRIMER KRONIS
by: Ni Luh Putu Ayu Maha Iswari, et al.
Published: (2013-04-01)

Treatment with beta-adrenoceptor blockers reduces plasma melatonin concentration.
by: Cowen, P, et al.
Published: (1985)

Melatonin for Insomnia in Medical Inpatients: A Narrative Review
by: Christine Salahub, et al.
Published: (2022-12-01)

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
by: Wade Alan G, et al.
Published: (2010-08-01)

Melatonin Treatment for Pediatric Patients with Insomnia: Is There a Place for It?
by: Rolling J, et al.
Published: (2022-10-01)

Effects of Melatonin-Rich Milk on Mild Insomnia Symptoms
by: Sahng Mee Bae, et al.
Published: (2016-12-01)

The Effectiveness of Prolonged-Release Melatonin in Primary Insomnia Patients with a Regular Sleep-Wake Cycle
by: Seockhoon Chung, et al.
Published: (2016-06-01)

Melatonin concentrations in serum of primary glaucoma patients
by: Xiao-Ping Ma, et al.
Published: (2018-08-01)

Circadian Rhythms of Melatonin Secretion in Peri- and Postmenopausal Women with Insomnia
by: Irina M. Madaeva, et al.
Published: (2017-06-01)

An open trial of cognitive therapy for chronic insomnia.
by: Harvey, A, et al.
Published: (2007)

Regulatory aspects and evidences of melatonin use for sleep disorders and insomnia: an integrative review
by: Ana Paula Rosinski Bueno, et al.
Published: (2021-09-01)

Relationship of nocturnal concentrations of melatonin, gamma-aminobutyric acid and total antioxidants in peripheral blood with insomnia after stroke: study protocol for a prospective non-randomized controlled trial
by: Wei Zhang, et al.
Published: (2017-01-01)

Prolonged-release melatonin for insomnia &ndash; an open-label long-term study of efficacy, safety, and withdrawal
by: Lemoine P, et al.
Published: (2011-07-01)

The Relationship Between PSG and Morning/Evening Emotional Parameters in Patients With Insomnia Disorder and Good Sleepers
by: Bernd Feige, et al.
Published: (2019-01-01)

The effect of clonidine and bright light on plasma melatonin
by: Grasby, P, et al.
Published: (1988)

Risk of dementia in patients with primary insomnia: a nationwide population-based case-control study
by: Chao-Ming Hung, et al.
Published: (2018-02-01)

Melanopic irradiance defines the impact of evening display light on sleep latency, melatonin and alertness
by: Isabel Schöllhorn, et al.
Published: (2023-03-01)

Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study
by: Garfinkel D, et al.
Published: (2011-08-01)

Direct radioimmunoassay for melatonin in plasma.
by: Fraser, S, et al.
Published: (1983)

Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
by: Srujitha Marupuru, et al.
Published: (2022-08-01)

Melatonin In Acute Mania Investigation (MIAMI‐UK): A randomised controlled trial of add‐on melatonin in bipolar disorder
by: Quested, DJ, et al.
Published: (2020)

Brain glutamate in anorexia nervosa: A magnetic resonance spectroscopy case control study at 7 Tesla
by: Godlewska, B, et al.
Published: (2016)

Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
by: Nadeem, H, et al.
Published: (2004)

MELATONIN VS BENZODIAZEPINES IN PHARMACOTHERAPY OF INSOMNIAS: POSITIVE AND NEGATIVE SIDES OF BOTH (A REVIEW OF THE LITERATURE)
by: Yuriy Vitalevich Bykov, et al.
Published: (2016-07-01)

New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists
by: R&uuml;diger Hardeland
Published: (2009-06-01)

Neuroendocrine regulation and metabolism of glucose and lipids in primary chronic insomnia: a prospective case-control study.
by: Eleonora Seelig, et al.
Published: (2013-01-01)

Effects of typhoid vaccine on inflammation and sleep in healthy participants: a double-blind, placebo-controlled, crossover study
by: Sharpley, A, et al.
Published: (2016)

In response to "The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?" by Trevor Norman.
by: Sharpley, A, et al.
Published: (2012)

Effect of pharmacologic treatments on the sleep of depressed patients.
by: Sharpley, A, et al.
Published: (1995)

Non-pharmacological management of chronic insomnia in primary care.
by: McKinstry, B, et al.
Published: (2008)